ArticleTranslational vision science & technology2026
Retinal Vascularity Index in Mild Cognitive Impairment.
Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Purpose: The purpose of this study was to determine whether retinal vascularity index (RVI) differs between individuals with mild cognitive impairment (MCI) and normal cognition, and to assess RVI as a novel ultra-widefield (UWF) implementation of retinal arteriovenous assessment. Methods: In a cross-sectional case-control study, UWF fundus color images from patients with MCI and cognitively healthy controls were analyzed using a semi-automated platform via the Comprehensive Ocular Imaging Network (COIN; ocularimaging.net). RVI was calculated as the ratio of arterial-to-venous cross-sectional area within a 47-degree region of interest (ROI) centered on the optic disc, with quadrant-based segmentation producing regional RVI values for 4 quadrants within the 47-degree ROI. Generalized estimating equations (GEEs) accounted for inter-eye correlation. Results: Fifty-five eyes of 38 patients with MCI and 89 eyes of 55 cognitively healthy patients were included. Mean RVI across the 47-degree ROI was reduced in MCI versus control eyes (0.524 vs. 0.730, P < 0.001) after adjusting for treated hypertension. Reduced RVI was also observed in each of the four quadrants in MCI compared with controls (P < 0.001). RVI showed good discriminative ability (area under the curve [AUC] = 0.86, sensitivity = 80%, and specificity = 79%) with good inter-grader reliability (intraclass correlation coefficient [ICC] = 0.840, 95% confidence interval [CI] = 0.686-0.943). Conclusions: Mean RVI across the 47-degree ROI was significantly lower in individuals with MCI compared with cognitively healthy controls. Translational Relevance: RVI, derived from UWF imaging, may reflect retinal microvascular cross-sectional area differences associated with MCI. As an exploratory metric, further validation is needed before RVI can be used as a noninvasive tool to complement diagnostic approaches for MCI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.